PubMed

Correction: Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes.

Stefansson OA, Jonasson JG, Johannsson OT, Olafsdottir K, Steinarsdottir M, Valgeirsdottir S, Eyfjord JE.

Breast Cancer Res. 2009 Sep 2;11(5):404. [Epub ahead of print]PMID: 19735587 [PubMed - as supplied by publisher]Related articles

Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes.

Stefansson OA, Jonasson JG, Johannsson OT, Olafsdottir K, Steinarsdottir M, Valgeirsdottir S, Eyfjord JE.

Breast Cancer Res. 2009;11(4):R47. Epub 2009 Jul 9.PMID: 19589159 [PubMed - in process]Related articlesFree article

BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts.

Jonsdottir AB, Vreeswijk MP, Wolterbeek R, Devilee P, Tanke HJ, Eyfjörd JE, Szuhai K.

Cell Oncol. 2009;31(3):191-201.PMID: 19478387 [PubMed - indexed for MEDLINE]Related articles

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.

Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, Risch HA, Eyfjord JE, Hopper JL, Southey MC, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tryggvadottir L, Syrjakoski K, Kallioniemi OP, Eerola H, Nevanlinna H, Pharoah PD, Easton DF.

Br J Cancer. 2008 Apr 22;98(8):1457-66. Epub 2008 Mar 18. Erratum in: Br J Cancer. 2008 Jun 17;98(12):2015. Passini, B [corrected to Pasini, B]. PMID: 18349832 [PubMed - indexed for MEDLINE]Related articlesFree article

AURKA and breast cancer in BRCA1/2 mutation carriers.

Bodvarsdottir SK, Vidarsdottir L, Eyfjord JE.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2517. No abstract available. PMID: 18006949 [PubMed - indexed for MEDLINE]Related articlesFree article

Positive association between DNA strand breaks in peripheral blood mononuclear cells and polyunsaturated fatty acids in red blood cells from women.

Thorlaksdottir AY, Jonsson JJ, Tryggvadottir L, Skuladottir GV, Petursdottir AL, Ogmundsdottir HM, Eyfjord JE, Hardardottir I.

Nutr Cancer. 2007;59(1):21-8.PMID: 17927498 [PubMed - indexed for MEDLINE]Related articles

Positive association between plasma antioxidant capacity and n-3 PUFA in red blood cells from women.

Thorlaksdottir AY, Skuladottir GV, Petursdottir AL, Tryggvadottir L, Ogmundsdottir HM, Eyfjord JE, Jonsson JJ, Hardardottir I.

Lipids. 2006 Feb;41(2):119-25.PMID: 17707977 [PubMed - indexed for MEDLINE]Related articles

MYC amplification and TERT expression in breast tumor progression.

Bodvarsdóttir SK, Steinarsdóttir M, Hilmarsdóttir H, Jónasson JG, Eyfjörd JE.

Cancer Genet Cytogenet. 2007 Jul 15;176(2):93-9.PMID: 17656250 [PubMed - indexed for MEDLINE]Related articles

Prostate cancer progression and survival in BRCA2 mutation carriers.

Tryggvadóttir L, Vidarsdóttir L, Thorgeirsson T, Jonasson JG, Olafsdóttir EJ, Olafsdóttir GH, Rafnar T, Thorlacius S, Jonsson E, Eyfjord JE, Tulinius H.

J Natl Cancer Inst. 2007 Jun 20;99(12):929-35. Epub 2007 Jun 12.PMID: 17565157 [PubMed - indexed for MEDLINE]Related articlesFree article

Breast cancer risk associated with AURKA 91T -->A polymorphism in relation to BRCA mutations.

Vidarsdottir L, Bodvarsdottir SK, Hilmarsdottir H, Tryggvadottir L, Eyfjord JE.

Cancer Lett. 2007 Jun 8;250(2):206-12. Epub 2006 Nov 17.PMID: 17113223 [PubMed - indexed for MEDLINE]Related articles

Aurora-A amplification associated with BRCA2 mutation in breast tumours.

Bodvarsdottir SK, Hilmarsdottir H, Birgisdottir V, Steinarsdottir M, Jonasson JG, Eyfjord JE.

Cancer Lett. 2007 Apr 8;248(1):96-102. Epub 2006 Jul 24.PMID: 16860930 [PubMed - indexed for MEDLINE]Related articles

Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.

Birgisdottir V, Stefansson OA, Bodvarsdottir SK, Hilmarsdottir H, Jonasson JG, Eyfjord JE.

Breast Cancer Res. 2006;8(4):R38.PMID: 16846527 [PubMed - indexed for MEDLINE]Related articlesFree article

Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.

Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, Eyfjörd JE.

J Natl Cancer Inst. 2006 Jan 18;98(2):116-22.PMID: 16418514 [PubMed - indexed for MEDLINE]Related articlesFree article

Genomic instability and cancer: networks involved in response to DNA damage.

Eyfjord JE, Bodvarsdottir SK.

Mutat Res. 2005 Dec 30;592(1-2):18-28. Epub 2005 Jul 5. Review.PMID: 16002101 [PubMed - indexed for MEDLINE]Related articles

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies.

Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF.

J Med Genet. 2005 Jul;42(7):602-3.PMID: 15994883 [PubMed - indexed for MEDLINE]Related articlesFree article

The Icelandic founder mutation BRCA2 999del5: analysis of expression.

Mikaelsdottir EK, Valgeirsdottir S, Eyfjord JE, Rafnar T.

Breast Cancer Res. 2004;6(4):R284-90. Epub 2004 Apr 7.PMID: 15217494 [PubMed - indexed for MEDLINE]Related articlesFree article

BRCA2 mutation carriers, reproductive factors and breast cancer risk.

Tryggvadottir L, Olafsdottir EJ, Gudlaugsdottir S, Thorlacius S, Jonasson JG, Tulinius H, Eyfjord JE.

Breast Cancer Res. 2003;5(5):R121-8. Epub 2003 Jun 24.PMID: 12927042 [PubMed - indexed for MEDLINE]Related articlesFree article

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF.

Am J Hum Genet. 2003 May;72(5):1117-30. Epub 2003 Apr 3. Erratum in: Am J Hum Genet. 2003 Sep;73(3):709. PMID: 12677558 [PubMed - indexed for MEDLINE]Related articlesFree article

CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status.

Gudmundsdottir K, Thorlacius S, Jonasson JG, Sigfusson BF, Tryggvadottir L, Eyfjord JE.

Br J Cancer. 2003 Mar 24;88(6):933-6.PMID: 12644832 [PubMed - indexed for MEDLINE]Related articlesFree article

DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity.

Yuan BZ, Zhou X, Durkin ME, Zimonjic DB, Gumundsdottir K, Eyfjord JE, Thorgeirsson SS, Popescu NC.

Oncogene. 2003 Jan 23;22(3):445-50.PMID: 12545165 [PubMed - indexed for MEDLINE]Related articles

BRCA1 and BRCA2 bind Stat5a and suppress its transcriptional activity.

Vidarsson H, Mikaelsdottir EK, Rafnar T, Bertwistle D, Ashworth A, Eyfjord JE, Valgeirsdottir S.

FEBS Lett. 2002 Dec 4;532(1-2):247-52.PMID: 12459499 [PubMed - indexed for MEDLINE]Related articles

The effect of a single BRCA2 mutation on cancer in Iceland.

Tulinius H, Olafsdottir GH, Sigvaldason H, Arason A, Barkardottir RB, Egilsson V, Ogmundsdottir HM, Tryggvadottir L, Gudlaugsdottir S, Eyfjord JE.

J Med Genet. 2002 Jul;39(7):457-62.PMID: 12114473 [PubMed - indexed for MEDLINE]Related articlesFree article

Breast cancer risk factors and age at diagnosis: an Icelandic cohort study.

Tryggvadóttir L, Tulinius H, Eyfjord JE, Sigurvinsson T.

Int J Cancer. 2002 Apr 1;98(4):604-8.PMID: 11920622 [PubMed - indexed for MEDLINE]Related articles

GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene.

Gudmundsdottir K, Tryggvadottir L, Eyfjord JE.

Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1169-73.PMID: 11700265 [PubMed - indexed for MEDLINE]Related articlesFree article

Breastfeeding and reduced risk of breast cancer in an Icelandic cohort study.

Tryggvadóttir L, Tulinius H, Eyfjord JE, Sigurvinsson T.

Am J Epidemiol. 2001 Jul 1;154(1):37-42.PMID: 11427403 [PubMed - indexed for MEDLINE]Related articlesFree article

p53 abnormality and chromosomal instability in the same breast tumor cells.

Sigurdsson S, Bödvarsdottir SK, Anamthawat-Jonsson K, Steinarsdottir M, Jonasson JG, Ogmundsdottir HM, Eyfjörd JE.

Cancer Genet Cytogenet. 2000 Sep;121(2):150-5.PMID: 11063799 [PubMed - indexed for MEDLINE]Related articles

P53 mutations analysis in benign and malignant breast lesions: using needle rinses from fine-needle aspirations.

Gudlaugsdottir S, Sigurdardottir V, Snorradottir M, Jonasson JG, Ogmundsdottir H, Eyfjord JE.

Diagn Cytopathol. 2000 May;22(5):268-74.PMID: 10790231 [PubMed - indexed for MEDLINE]Related articles

Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma.

van Slooten HJ, van De Vijver MJ, Borresen AL, Eyfjörd JE, Valgardsdóttir R, Scherneck S, Nesland JM, Devilee P, Cornelisse CJ, van Dierendonck JH.

J Pathol. 1999 Dec;189(4):504-13.PMID: 10629550 [PubMed - indexed for MEDLINE]Related articles

Population-based study of risk of breast cancer in carriers of BRCA2 mutation.

Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H, Eyfjörd JE.

Lancet. 1998 Oct 24;352(9137):1337-9.PMID: 9802270 [PubMed - indexed for MEDLINE]Related articles

BRCA2 germline mutations in Swedish breast cancer families.

Chen J, Hedman MZ, Arver BW, Sigurdsson S, Eyfjörd JE, Lindblom A.

Eur J Hum Genet. 1998 Mar-Apr;6(2):134-9.PMID: 9781057 [PubMed - indexed for MEDLINE]Related articlesFree article

deCODE deferred.

Eyfjörd JE, Ogmundsdottir HM, Eggertsson G, Zoëga T.

Nat Biotechnol. 1998 Jun;16(6):496. No abstract available. PMID: 9624667 [PubMed - indexed for MEDLINE]Related articles

Simultaneous detection of p53 nuclear protein and chromosome aberrations on sections from formalin-fixed, paraffin-embedded breast cancer tissue.

Bödvarsdóttir SK, Sigurdsson S, Steinarsdóttir M, Eyfjörd JE, Ogmundsdóttir H, Anamthawat-Jónsson K.

Chromosome Res. 1998 Apr;6(3):233-5. No abstract available. PMID: 9609668 [PubMed - indexed for MEDLINE]Related articles

BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability.

Gretarsdottir S, Thorlacius S, Valgardsdottir R, Gudlaugsdottir S, Sigurdsson S, Steinarsdottir M, Jonasson JG, Anamthawat-Jonsson K, Eyfjörd JE.

Cancer Res. 1998 Mar 1;58(5):859-62.PMID: 9500438 [PubMed - indexed for MEDLINE]Related articlesFree article

BRCA2 mutation in Icelandic prostate cancer patients.

Sigurdsson S, Thorlacius S, Tomasson J, Tryggvadottir L, Benediktsdottir K, Eyfjörd JE, Jonsson E.

J Mol Med. 1997 Oct;75(10):758-61.PMID: 9383000 [PubMed - indexed for MEDLINE]Related articles

Study of a single BRCA2 mutation with high carrier frequency in a small population.

Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, Tulinius H, Eyfjörd JE.

Am J Hum Genet. 1997 May;60(5):1079-84.PMID: 9150155 [PubMed - indexed for MEDLINE]Related articlesFree article

Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis.

Valgardsdottir R, Tryggvadottir L, Steinarsdottir M, Olafsdottir K, Jonasdottir S, Jonasson JG, Ogmundsdottir HM, Eyfjörd JE.

APMIS. 1997 Feb;105(2):121-30.PMID: 9113074 [PubMed - indexed for MEDLINE]Related articles

Molecular genetics and cytogenetics of breast carcinomas: comparison of the two methods.

Valgardsdottir R, Steinarsdottir M, Anamthawat-Jonsson K, Petursdottir I, Ogmundsdottir HM, Eyfjörd JE.

Cancer Genet Cytogenet. 1996 Nov;92(1):37-42.PMID: 8956869 [PubMed - indexed for MEDLINE]Related articles

TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material.

Gretarsdottir S, Tryggvadottir L, Jonasson JG, Sigurdsson H, Olafsdottir K, Agnarsson BA, Ogmundsdottir H, Eyfjörd JE.

Br J Cancer. 1996 Aug;74(4):555-61.PMID: 8761369 [PubMed - indexed for MEDLINE]Related articlesFree article

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.

Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ogmundsdottir HM, Eyfjörd JE.

Nat Genet. 1996 May;13(1):117-9.PMID: 8673089 [PubMed - indexed for MEDLINE]Related articles

Instability of chromosomes 1, 3, 16, and 17 in primary breast carcinomas inferred by fluorescence in situ hybridization.

Anamthawat-Jónsson K, Eyfjörd JE, Ogmundsdóttir HM, Pétursdóttir I, Steinarsdóttir M.

Cancer Genet Cytogenet. 1996 May;88(1):1-7.PMID: 8630972 [PubMed - indexed for MEDLINE]Related articles

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.

Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Mitchell JT, McArthur-Morrison J, Nguyen K, Peng Y, Samson C, Schroeder M, Snyder SC, Steele L, Stringfellow M, Stroup C, Swedlund B, Swense J, Teng D, Thomas A, Tran T, Tranchant M, Weaver-Feldhaus J, Wong AK, Shizuya H, Eyfjord JE, Cannon-Albright L, Tranchant M, Labrie F, Skolnick MH, Weber B, Kamb A, Goldgar DE.

Nat Genet. 1996 Mar;12(3):333-7.PMID: 8589730 [PubMed - indexed for MEDLINE]Related articles

Male breast cancer in Iceland.

Jonasson JG, Agnarsson BA, Thorlacius S, Eyfjord JE, Tulinius H.

Int J Cancer. 1996 Feb 8;65(4):446-9.PMID: 8621225 [PubMed - indexed for MEDLINE]Related articles

TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis.

Thorlacius S, Thorgilsson B, Björnsson J, Tryggvadottir L, Börresen AL, Ogmundsdottir HM, Eyfjörd JE.

Eur J Cancer. 1995 Oct;31A(11):1856-61.PMID: 8541113 [PubMed - indexed for MEDLINE]Related articles

TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.

Børresen AL, Andersen TI, Eyfjörd JE, Cornelis RS, Thorlacius S, Borg A, Johansson U, Theillet C, Scherneck S, Hartman S, et al.

Genes Chromosomes Cancer. 1995 Sep;14(1):71-5.PMID: 8527388 [PubMed - indexed for MEDLINE]Related articles

Linkage to BRCA2 region in hereditary male breast cancer.

Thorlacius S, Tryggvadottir L, Olafsdottir GH, Jonasson JG, Ogmundsdottir HM, Tulinius H, Eyfjord JE.

Lancet. 1995 Aug 26;346(8974):544-5.PMID: 7658781 [PubMed - indexed for MEDLINE]Related articles

Cytogenetic studies of breast carcinomas: different karyotypic profiles detected by direct harvesting and short-term culture.

Steinarsdóttir M, Pétursdóttir I, Snorradóttir S, Eyfjörd JE, Ogmundsdóttir HM.

Genes Chromosomes Cancer. 1995 Aug;13(4):239-48.PMID: 7547631 [PubMed - indexed for MEDLINE]Related articles

p53 abnormalities and genomic instability in primary human breast carcinomas.

Eyfjörd JE, Thorlacius S, Steinarsdottir M, Valgardsdottir R, Ogmundsdottir HM, Anamthawat-Jonsson K.

Cancer Res. 1995 Feb 1;55(3):646-51.PMID: 7530599 [PubMed - indexed for MEDLINE]Related articlesFree article

TP53 abnormalities and genetic instability in breast cancer.

Eyfjörd JE, Thorlacius S, Valgardsdottir R, Gretarsdottir S, Steinarsdottir M, Anamthawat-Jonsson K.

Acta Oncol. 1995;34(5):663-7.PMID: 7546836 [PubMed - indexed for MEDLINE]Related articles

Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.

Thorlacius S, Börresen AL, Eyfjörd JE.

Cancer Res. 1993 Apr 1;53(7):1637-41.PMID: 8453635 [PubMed - indexed for MEDLINE]Related articlesFree article

Genetic changes in breast carcinomas in an Icelandic population.

Eyfjörd JE, Thorlacius S.

Pharmacogenetics. 1992 Dec;2(6):309-16.PMID: 1306132 [PubMed - indexed for MEDLINE]Related articles